Pulmonary tumor thrombotic microangiopathy: FDG-PET/CT findings.
Pulmonary tumor thrombotic microangiopathy (PTTM) is histopathologically characterized by proliferation of intimal myofibroblasts in the small pulmonary arterioles, induced by tumor microemboli. Patients develop rapidly progressive and severe cardiopulmonary failure, and the clinical course of this disease is fatal. Conventional radiologic findings are often minimal or nonspecific, making diagnosis difficult before death. We report 2-(F-18)-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) images of PTTM, which illustrate the characteristic findings of this clinical entity. FDG-PET can be helpful for the diagnosis of PTTM.
Tashima
Yoshiko
Y
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abe
Koichiro
K
Matsuo
Yoshio
Y
Baba
Shingo
S
Kaneko
Koichiro
K
Isoda
Takuro
T
Yabuuchi
Hidetake
H
Sasaki
Masayuki
M
Honda
Hiroshi
H
D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply* / Q000473:pathology; D008875:Middle Aged; D049268:Positron-Emission Tomography; D011651:Pulmonary Artery / Q000000981:diagnostic imaging / Q000473:pathology*; D013927:Thrombosis / Q000503:physiopathology*; D014057:Tomography, X-Ray Computed
D019788:Fluorodeoxyglucose F18